<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-054905</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Intravitreal toxicity of doxycycline. A pilot study</dc:title>
<dc:description xml:lang="en">Objective: To assess the retinal toxicity of varying        concentrations of intravitreally administered        doxycycline, a member of tetracycline family.        Methods: Fourteen New Zealand albino rabbits,        divided into 5 groups, were used for this study. The        initial concentration of doxycycline (100 mg) was        titrated using 5% dextrose solution to the following        concentrations in a volume of 0.1 ml: 2000 ìg,        1000 mg, 500 mg, 250 mg, 125 mg, and 62.5 mg. Each        concentration was injected into 2 rabbit eyes. Two        control eyes received 0.1 ml of 5% dextrose solution.        All animals were examined before and after        injection using indirect ophthalmoscopy and        slit&#150;lamp biomicroscopy. Electroretinography        (ERG) was performed on all animals prior to the        intravitreal injection and 2 weeks post-injection.        The animals were re-examined at this time by indirect        ophthalmoscopy and slit&#150;lamp biomicroscopy        and were then subjected to euthanasia. Their eyes        were enucleated and examined using light microscopy.        Results: The doxycycline injected group exhibited        significant decreases in ERG of the eyes injected        with 2000 mg, 1000 mg, 500 mg, and 250 mg/0.1 ml.        No significant changes in the ERG were observed following the injection of lesser concentration        levels. There were no signs of retinal toxicity on        slit-lamp examination, indirect ophthalmoscopy, or        light microscopy in all the eyes injected with        doxycycline concentrations of 125 mg or lower.        Conclusions: Doxycycline injected intravitreally        appeared safe at concentrations of 125 mg/0.1 ml or        less in albino rabbits. Intravitreal doxycycline may        be beneficial, and is an inexpensive alternative drug        which could be used in the treatment of bacterial        endophthalmitis particularly against resistant        Staphylococcus aureus organisms</dc:description>
<dc:creator>Kazi, A. A</dc:creator>
<dc:creator>Peyman, G. A</dc:creator>
<dc:creator>Esfahani, M. R</dc:creator>
<dc:creator>Aydin, E</dc:creator>
<dc:creator>Kivilcim, M</dc:creator>
<dc:creator>Muñoz-Morales, A</dc:creator>
<dc:creator>Caro-Magdaleno, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Valorar la toxicidad retiniana de la doxiciclina        administrada en inyecciones intravítreas.        Método: Utilizamos catorce conejos albinos neozelandeses        que dividimos en 5 grupos. Inyectamos en        dos ojos cada una de las siguientes concentraciones        de doxiciclina: 2.000 ìg/0,1 ml; 500 ìg/0,1 ml; 250        ìg/0,1 ml; 125 ìg/0,1 ml y 67,5 ìg/0,1 ml. Dos        ojos, usados como control, recibieron 0,1 ml de        solución de dextrosa al 5%. Examinamos a todos        los animales antes y después de la inyección con        oftalmoscopía indirecta y biomicroscopía. Realizamos        electrorretinogramas en todos antes de la        inyección intravítrea y dos semanas después; y posteriormente        los animales fueron eutanizados. Se        enuclearon los ojos y se prepararon para estudio        histológico.        Resultados: Los grupos que mostraron una disminución        significativa en los electrorretinogramas        fueron los inyectados con las siguientes concentraciones        de doxiciclina: 2.000 ìg/0,1 ml; 500 ìg/0,1        ml y 250 ìg/0,1 ml. No se observaron cambios significativos        en los electrorretinogramas de los inyectados        con 125 y 67,5 ìg/0,1 ml. No hubo signos de        toxicidad retiniana en los exámenes de biomicroscopía,        en oftalmoscopía indirecta e histología de los inyectados con 125 ìg/0,1 ml o niveles menores de        doxiciclina.        Conclusión: Las inyecciones intravítreas de doxiciclina        parecen seguras en un rango igual o menor a        125 ìg/0,1 ml en el conejo albino. La doxiciclina        intravítrea podría ser una alternativa barata y beneficiosa        para el tratamiento de la endoftalmitis, especialmente        frente a los staphylococcus aureus resistentes</dc:description>
<dc:source>Arch Soc Esp Oftalmol;82(4): 223-228, abr. 2007. ilus</dc:source>
<dc:identifier>ibc-054905</dc:identifier>
<dc:title xml:lang="es">Toxicidad retiniana de doxiciclina intravitrea. Estudio piloto</dc:title>
<dc:subject>^d12584^s22012</dc:subject>
<dc:subject>^d12256</dc:subject>
<dc:subject>^d841</dc:subject>
<dc:subject>^d10067^s22045</dc:subject>
<dc:subject>^d28297^s22057</dc:subject>
<dc:subject>^d12584^s22016</dc:subject>
<dc:subject>^d12581^s22016</dc:subject>
<dc:subject>^d12578^s22021</dc:subject>
<dc:subject>^d30933^s22073</dc:subject>
<dc:subject>^d12581^s22067</dc:subject>
<dc:subject>^d30933^s22068</dc:subject>
<dc:subject>^d4421^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>200704</dc:date>
</metadata>
</record>
</ibecs-document>
